CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: BIO 2016 (619) Pharma Startups (6570)
Protalix Biotherapeutics is a biopharmaceutical company that is focused on the development and commercialization of proprietary recombinant therapeutic proteins expressed through its proprietary ProCellEx plant cell-based protein expression system. U...Show all
Company (IPO / Went public)
Phone: +972-4-902-8100
2 Snunit St., Science Park
POB 455
Carmiel, 20100
Israel
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same | Jul 26, 2018 | Aug 04, 2020 | Patent |
| Large scale disposable bioreactor | May 05, 2008 | Jul 30, 2019 | Patent |
| Stabilized alpha-galactosidase and uses thereof | Jun 29, 2017 | May 07, 2019 | Patent |
| Use of plant cells expressing a tnfalpha polypeptide inhibitor in therapy | Mar 06, 2014 | Oct 02, 2018 | Patent |
| Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same | Sep 10, 2015 | Jun 19, 2018 | Patent |
